Hiroki Uehara

Statistics

Publications

Citations

295

H-Index

Active since

2013

Affiliations

Yokohama City University Medical Center(Current)

National Cerebral and Cardiovascular Center

Yokohama City University

Toho University

Toho University Ohashi Medical Center

Hiroki Uehara is an author at Yokohama City University Medical Center specializing in cardiovascular pharmacotherapy, medicine, and clinical cardiology.

ORCID

Publications per year

2013–2024

Publications

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent Implantation

Masato Nakamura, Raisuke Iijima, Junya Ako et al. · JACC: Cardiovascular Interventions · 2017 · 115 citations

Medicine, Pharmacotherapy, Cardiovascular Pharmacotherapy +14

Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting

Tetsuya Matoba, Satoshi Yasuda, Koichi Kaikita et al. · JACC: Cardiovascular Interventions · 2021 · 22 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease

Ryo Naito, Katsumi Miyauchi, Satoshi Yasuda et al. · JAMA Cardiology · 2022 · 14 citations · Full text

Medicine, Cardiology, Pharmacology +17

Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial

Yuki Obayashi, Masahiro Natsuaki, Hirotoshi Watanabe et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2024 · 12 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

1–5 of 6